ABSTRACT
Introduction Innovative HIV technologies can help to reduce HIV incidence, yet uptake of such tools is relatively low among young people. To create awareness and demand among adolescents and young adults, a new campaign of the pan-African MTV Shuga series (“Down South 2”; DS2), featured storylines and messages about HIV self-testing (HIVST) and pre-exposure prophylaxis (PrEP) through television, radio and accompanying multimedia activities in 2019-2020.
Methods We conducted a mixed-methods evaluation of the new MTV Shuga series among 15-24 year-olds in Eastern Cape, South Africa, in 2020. A web-based survey, promoted via social media platforms of schools, universities, and communities, assessed exposure to MTV Shuga and knowledge of HIV status; secondary outcomes included awareness and uptake of HIVST and PrEP. An embedded qualitative evaluation explored mechanisms of MTV Shuga’s impact through in-depth individual and group interviews.
Results Among 3,431 online survey participants, 43% had engaged with MTV Shuga and 24% with DS2 specifically. Knowledge of HIV status was higher among those exposed to DS2 (58%) versus those who were not (35%; adjusted OR=2.06 [95% CI:1.64-2.58]). Exposure was also associated with increased awareness of HIVST (60% vs 28%; aOR=1.99[1.61-2.47]) and use of HIVST (29% vs 10%; aOR=2.49[1.95-3.19]). One-third of respondents were aware of PrEP, with higher proportions among those exposed versus non-exposed to DS2 (52% vs 27%; aOR=1.90[1.53-2.35]). Qualitative insights identified mechanisms by which DS2 increased awareness, confidence and motivation to use HIVST and PrEP, but had less influence on service access.
Conclusions We found evidence consistent with a positive causal impact of the MTV Shuga DS2 campaign on HIV prevention outcomes among young people in a high-prevalence setting. As diverse testing and PrEP technologies become accessible, an immersive edutainment campaign can help to expand HIV prevention choices and close age and gender gaps in HIV testing and prevention goals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported through a grant from Unitaid through a sub-contract from MTV Staying Alive Foundation to London School of Hygiene & Tropical Medicine, grant 1317919.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committees of LSHTM, University of KwaZulu-Natal, and the World Health Organisation gave ethics approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
